• No results found

Loss of MKK3 and MK2 Copy Numbers in Non-Small Cell Lung Cancer

N/A
N/A
Protected

Academic year: 2022

Share "Loss of MKK3 and MK2 Copy Numbers in Non-Small Cell Lung Cancer"

Copied!
4
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

This study assessed the prognostic impact of FGF2 and FGFR-1 in tumor cells and tumor stroma of resected non-small cell lung carcinomas (NSCLC) and, based on interesting

Prognostic impact of CXCL16 and CXCR6 in non- small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival.. Stromal CD8+

Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. 2016 Open Access

Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial..

The cell lines used in this study were the human non- small cell lung cancer cell lines (A549), ovarian cancer cell line (A2780), pancreatic cancer cell line (MIA-Paca-2), and

Progesterone and estrogen receptor expression and activity in human non-small cell lung cancer.. A life-long search for the molecular pathways of steroid hormone

This study investigates correlations between CAF and immune-markers in tumor stroma from non- small cell lung cancer (NSCLC) patients, and examines whether a combination of CAF

Introduction of miR-210 in NSCLC patients expressing low tumor levels may be a potential future treatment approach, especially since miR-210 is associated with a positive